Tepha buys its way out of Metabolix bioresorbables deal

Absorbable biomaterial developer Metabolix said it amended its license agreement with medical device company Tepha, forgoing future royalties and providing 2 additional Metabolix production strains and related IP in exchange for a $2 million lump sum.

Read the full story at our sister site, Medical Design & Outsourcing.

The post Tepha buys its way out of Metabolix bioresorbables deal appeared first on MassDevice.

from MassDevice http://ift.tt/1UjDlaN